The role of reactive oxygen species in the transformation from prostatitis to prostate cancer: a review

The role of reactive oxygen species in the transformation from prostatitis to prostate cancer: a review

In the study of prostate diseases, the microenvironment associated with chronic prostatitis is characterized by abnormal activation of immune cells, leading to excessive accumulation of pro-inflammatory factors and an imbalance in the antioxidant defense system. This results in the overproduction of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kaihua Tang, Zhipeng Jiang, Wen Luo, Jing Li, DeCan Liang, Lei Liu, ZongMin Long
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Immunology
Subjects:	reactive oxygen species oxidative stress prostatitis prostate cancer tumor microenvironment inflammation-cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1662792/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Molecular genetic aspects of prostate cancer radioresistance
by: E. P. Omelchuk, et al.
Published: (2021-10-01)

STAMP2 increases oxidative stress and is critical for prostate cancer
by: Yang Jin, et al.
Published: (2015-02-01)

Usefulness of prostate specific antigen density in detecting prostate carcinoma: A hospital-based study in patients with prostate biopsies
by: Reshmi Shrestha, et al.
Published: (2022-03-01)

Optimization of HIFU monotherapy for prostate cancer
by: K. V. Pozdnyakov, et al.
Published: (2022-04-01)

Clinical significance of the phenotype of immune cells of the tumor stroma of prostate cancer
by: P. A. Podlesnaya, et al.
Published: (2022-03-01)

The impact of exercise on prostate-specific antigen and testosterone in prostate cancer: a systematic review and meta-analysis
by: Fuxun Zhang, et al.
Published: (2025-12-01)

Neoadjuvant prostate artery embolization prior to prostate radiation therapy: A single institution experience on the durability of clinical urinary improvement after radiation
by: Vaseem M. Khatri, et al.
Published: (2025-11-01)

Male sexuality and the risk of developing benign prostatic hyperplasia and prostate cancer: is there a connection?
by: M. I. Kogan, et al.
Published: (2025-07-01)

Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: The results of a Delphi consensus project
by: Andrea Cocci, et al.
Published: (2024-04-01)

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01)

COMPUTER TOMOGRAPHY IN DIAGNOSIS OF DISEASES AND NEW FORMATIONS OF THE PROSTATE GLAND
by: D. E. Baikov, et al.
Published: (2017-07-01)

Prostate cancer management—helping your patient choose what is best for him
by: Christiaan F. Heyns, et al.
Published: (2008-10-01)

Non-invasive MRI-based assessment of reactive stromal grade in prostate cancer using diffusion kurtosis imaging and stretched-exponential model
by: Kun-Peng Zhou, et al.
Published: (2025-08-01)

DIAGNOSTIC VALUE OF DEFINITION OF FRACTIONS OF PROSTATIC SPECIFIC ANTIGEN AND PROSTATE HEALTH INDEX
by: A. S. Al-Shukri, et al.
Published: (2017-04-01)

Multi-omic insights into mitochondrial dysfunction and prostatic disease: evidence from transcriptomics, proteomics, and methylomics
by: Binbin Gong, et al.
Published: (2025-08-01)

Evaluation of human papillomavirus as a risk factor in prostate cancer pathogenesis
by: Richard Maliye, et al.
Published: (2025-07-01)

POWER DOPPLER IMAGING IN PATIENTS WITH SUSPECTED PROSTATE CANCER
by: T. V. Shatylko, et al.
Published: (2016-09-01)

“Superscan” Scintigraphic Version for Prostate Cancer
by: S. P. Mironov, et al.
Published: (2023-06-01)

HistoScanning<sup>TM</sup> vs. standard multifocal biopsy for prostate cancer diagnosis: a comparison of diagnostic methods
by: S. V. Kotov, et al.
Published: (2023-12-01)

On the role of diagnosis of prostate diseases at the outpatient appointment of a therapist
by: A. L. Kebina, et al.
Published: (2022-01-01)

Multicentre assessment of transperineal targeted prostate biopsy performed as part of a targeted and systematic biopsy diagnostic strategy in men without previous prostate biopsies
by: Mohammed Sheweita, et al.
Published: (2025-04-01)

Comparison of Disease Progression From Prostate Cancer Diagnosis to Metastatic or Nonmetastatic Castrate‐Resistant Prostate Cancer (CRPC) Patients: CaPA Study
by: Pedro Costa, et al.
Published: (2025-08-01)

Role of brachytherapy in the treatment of localized prostate cancer
by: A. D. Kaprin, et al.
Published: (2015-12-01)

THE BENEFITS OF PHYSICAL ACTIVITY IN MEN WITH PROSTATE CANCER - A SYSTEMATIC REVIEW
by: Leonessa Boing, et al.

Outcomes of Surgical Treatment of Multiple Primary Colorectal and Prostate Cancer
by: I. S. Ignatov, et al.
Published: (2025-02-01)

Interaction of Pinostrobin Oxime and Leukomizin with reactive oxygen species in model systems
by: Ye. A. Rodnova, et al.
Published: (2011-10-01)

LU-177-PSMA TREATMENT FOR METASTATIC PROSTATE CANCER – CASE EXAMPLES OF MIRACLE RESPONSES
by: K. Kairemo, et al.
Published: (2018-03-01)

Resection of a singular metachronous testicular metastasis of prostate cancer: A case report
by: Marie Semmler, et al.
Published: (2025-06-01)

Identification of epithelial-mesenchymal transition prognostic signature associated with prognosis, tumor microenvironment, and therapeutic effect in prostate cancer
by: Yiyuan Li, et al.
Published: (2025-08-01)

Evaluation of thymidine kinase 1 and folate receptor alpha as potential biomarkers in prostate cancer
by: Sarah Ibrahim Ahmed, et al.
Published: (2025-08-01)

The Long-Term Dynamics of the Incidence of Prostate Cancer in the Omsk Region
by: V. L. Stasenko, et al.
Published: (2019-05-01)

The Investigation of Association Between Il-10 -1082 Polymorphism and Human Papillomavirus Infection in Prostatic Tissue Samples
by: Ebru ETEM, et al.
Published: (2012-12-01)

Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
by: Patricia Tai, et al.
Published: (2025-07-01)

Expanding the usage of cryoablation as focal therapy for prostate tumour near the rectum
by: Yiu Chung Lam, et al.
Published: (2024-03-01)

Reactive oxygen species in polycystic ovary syndrome: Mechanistic insights into pathogenesis and therapeutic opportunities
by: Huanju Liu, et al.
Published: (2025-09-01)

Unlocking the Potential of <i>Gracilaria chilensis</i> Against Prostate Cancer
by: Verónica Torres-Estay, et al.
Published: (2025-07-01)

Predictive value of inflammatory marker PLR in prostate cancer
by: Junhao Sun, et al.
Published: (2025-08-01)

COPING STRATEGIES IN PATIENTS WITH PROSTATE CANCER
by: J. R. Gardanova, et al.
Published: (2016-01-01)

Correlation of expression of Cyclin D1 and E-cadherin with gleason grade, serum prostate specific antigen levels and prostatic volume in prostatic carcinoma
by: C Aatirah, et al.
Published: (2023-07-01)

Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer
by: L. V. Spirina, et al.
Published: (2019-04-01)